All Updates

All Updates

icon
Filter
Partnerships
Aranscia and Signature RX partner to optimize GLP-1 treatments with personalized medication management
Precision Medicine
Jun 20, 2024
This week:
Partnerships
Sheeva.AI and P97 Networks partner for in-car payment solutions at fuel stations
Auto Tech
Today
Product updates
Food Cycle Science launches 'Food Cycler Eco 3,' a household food waste processing bin
Food Waste
Yesterday
Partnerships
Von Holzhausen and Herman Miller partner to launch plant-based leather Eames Chair
Bio-based Materials
Yesterday
Partnerships
Volvo Cars partners with Beijing Shougang and Zhejiang Yiyun for automotive steel recycling
Waste Recovery & Management Tech
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Carbon Capture, Utilization & Storage (CCUS)
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Alternative Energy
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
Pet Care Tech
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
InsurTech: Personal Lines
Yesterday
M&A
Applied Systems acquires Planck for undisclosed sum to expand AI capabilities
InsurTech: Infrastructure
Yesterday
Product updates
Monzo launches pension consolidation product
Neobanks
Yesterday
Precision Medicine

Precision Medicine

Jun 20, 2024

Aranscia and Signature RX partner to optimize GLP-1 treatments with personalized medication management

Partnerships

  • Aranscia and Signature RX have partnered for the development of new biomarkers and personalized medication management solutions relating to GLP-1 treatments. GLP-1s are a class of medications indicated for chronic diseases like type 2 diabetes and obesity.

  • This partnership aims to expand the exploration of the pharmacogenomic parameters in GLP-1 receptor agonists, allowing more individualized and effective medication management and catering to the supply chain requirements of such medications. With the help of AccessDx Laboratory, an Aranscia subsidiary dedicated to developing new companion diagnostics for GLP-1 medications, and YouScript, a pharmacogenomics platform, a personalized program will be implemented to improve patient outcomes and reduce care costs. 

  • Aranscia specializes in diagnostic software and services that enhance precision medicine. The company’s portfolio includes solutions such as YouScript and 2bPrecise, a software suite that integrates genomic data into electronic medical records (EMRs) to assist healthcare providers in making informed decisions.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.